A Prospective Evaluation of the Analytical Performance of GENECUBE ® HQ SARS-CoV-2 and GENECUBE ® FLU A/B

ConclusionThe GENECUBE® HQ SARS-CoV-2 and GENECUBE® FLU A/B demonstrated sufficient analytical performance to detect SARS-CoV-2 and influenza virus A/B.

http://link.springer.com/10.1007/s40291-021-00535-5

Source: Molecular Diagnosis and Therapy - May 18, 2021 Category: Molecular Biology Source Type: research